Mesobiileal shunt in an infant for control of bleeding from gastroesophageal varices
Related Experiment Videos
1Department of Surgery, University of Rochester School of Medicine and Dentistry, N.Y.
Insights
Controlling bleeding gastroesophageal varices in children can be achieved through various methods. A novel portosystemic shunt is presented that maintains patency, even in infants, addressing thrombosis issues.
Area of Science:
- Pediatric Gastroenterology
- Hepatology
- Surgical Innovation
Background:
- Gastroesophageal varices are a significant concern in pediatric patients, often leading to bleeding episodes.
- Current treatments like sclerotherapy and ligation have limitations.
- Portosystemic shunts are effective in reducing portal venous pressure but suffer from high thrombosis rates in children.
Abstract:
There are various means to control bleeding gastroesophageal varices in children: sclerotherapy by injection, esophageal transection and variceal ligation, and different portosystemic shunts. Because of a high incidence of shunt thrombosis in children, many clinicians prefer other forms of therapy. However, only a successful shunt will lower the elevated portal venous pressure and eliminate the varices. This report describes a type of portosystemic shunt that will remain patent, even in an infant.